Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biotechnology and its public.

N Wade

    Technology in Society
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    This perspective examines biotechnology

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Effect of asthma and six-months high-intensity interval training on heart rate variability during exercise in adolescents.

    Journal of sports sciences·2019
    Same author

    Stem cell studies advance in Britain.

    The New York times on the Web·2002
    Same author

    An old question becomes new again: stem cell issue causes debate over the exact moment life begins.

    The New York times on the Web·2002
    Same author

    U.S. approves labs with stem cells for research use.

    The New York times on the Web·2002
    Same author

    For genome mappers, the tricky terrain of race requires some careful navigating.

    The New York times on the Web·2002
    Same author

    Scientist at work: Leon Kass: moralist of science ponders its power.

    The New York times on the Web·2002

    Area of Science:

    • Biotechnology
    • Molecular Biology
    • Genetic Therapy

    Background:

    • The history of the recombinant DNA research debate, starting with the 1975 Asilomar conference.
    • The call for a temporary moratorium on certain experiments to allow for guideline development by the National Institutes of Health (NIH).

    Observation:

    • Lobbying activities by molecular biologists against proposed federal, state, and local regulations.
    • The impact of commercialization on academic biologists, a shift from traditional involvement.

    Findings:

    • Congress did not enact legislation due to the responsible conduct of molecular biologists post-Asilomar.
    • The increasing ethical considerations and debates surrounding the powerful applications of biotechnology.

    Implications:

    Keywords:
    Asilomar ConferenceBiomedical and Behavioral ResearchGenetics and ReproductionLegal ApproachU.S. Congress
    • Biotechnology's advancement necessitates ongoing ethical discussions and the establishment of usage controls.
    • The commercialization of biotechnology presents new challenges and dynamics for academic research environments.